---
figid: PMC5511947__kjim-2016-302f1
figtitle: The downstream signaling cascade initiated by a hypoxic microenvironment
organisms:
- Mus musculus
- Rattus norvegicus
- Diaporthe sclerotioides
- Morchella esculenta
- Homo sapiens
pmcid: PMC5511947
filename: kjim-2016-302f1.jpg
figlink: /pmc/articles/PMC5511947/figure/f1-kjim-2016-302/
number: F1
caption: Schematic representation of the downstream signaling cascade initiated by
  a hypoxic microenvironment. Hypoxic response pathways result in cancer cells acquiring
  epithelial-mesenchymal transition (EMT) and stemness through hypoxia-inducible factor
  1α (HIF-1α) and HIF-2α. These phenotypic changes are regulated by epigenetic alterations.
  The EMT signaling pathway is primarily mediated by transforming growth factor β
  (TGF-β), Wnt, and other growth factors including endothelial growth factor (EGF),
  hepatocyte growth factor (HGF), insulin-like growth factor (IGF), and fibroblast
  growth factor (FGF) families. The primary transcription factors of EMT are Twist1/2,
  Snail, Slug, and zinc finger E-box-binding homeobox 1/2 (ZEB1/2). HIFs also target
  cancer stem cell (CSC)-associated signaling pathways and mediate transcriptional
  responses to hypoxia. Acquisition of stemness characteristics in epithelial cells
  can be induced by activation of the EMT process. Ultimately, cancer cells show tumor
  initiation, metastasis, and resistance to therapy. Oct4, octamer-binding transcription
  factor 4; SOX2, sex determining region Y-box 2; Klf4, Kruppel-like factor 4; NF-κB,
  nuclear factor κB; PI3K, phosphoinositide 3-kinase; MAPK/ ERK, mitogen-activated
  protein kinase/extracellular signal-related kinase; JAK-STAT, Janus kinase-signal
  transducer and activator of transcription; VEGF, vascular endothelial growth factor;
  ALDH1, aldehyde dehydrogenase 1 family; ABC, ATP-binding cassette; CD, cluster of
  differentiation; ABCG2, ATP-binding cassette sub-family G member 2; ALDH1A1, aldehyde
  dehydrogenase 1 family, member A1; EpCAM, epithelial cell adhesion molecule; SSEA4,
  stage-specific embryonic antigen-4; CXCR4, C-X-C chemokine receptor type 4; BMI-1,
  B lymphoma Mo-MLV insertion region 1 homolog.
papertitle: 'The role of hypoxia on the acquisition of epithelial-mesenchymal transition
  and cancer stemness: a possible link to epigenetic regulation.'
reftext: Chang Dong Yeo, et al. Korean J Intern Med. 2017 Jul;32(4):589-599.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.6166941
figid_alias: PMC5511947__F1
figtype: Figure
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
redirect_from: /figures/PMC5511947__F1
ndex: 84855bf6-de9f-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5511947__kjim-2016-302f1.html
  '@type': Dataset
  description: Schematic representation of the downstream signaling cascade initiated
    by a hypoxic microenvironment. Hypoxic response pathways result in cancer cells
    acquiring epithelial-mesenchymal transition (EMT) and stemness through hypoxia-inducible
    factor 1α (HIF-1α) and HIF-2α. These phenotypic changes are regulated by epigenetic
    alterations. The EMT signaling pathway is primarily mediated by transforming growth
    factor β (TGF-β), Wnt, and other growth factors including endothelial growth factor
    (EGF), hepatocyte growth factor (HGF), insulin-like growth factor (IGF), and fibroblast
    growth factor (FGF) families. The primary transcription factors of EMT are Twist1/2,
    Snail, Slug, and zinc finger E-box-binding homeobox 1/2 (ZEB1/2). HIFs also target
    cancer stem cell (CSC)-associated signaling pathways and mediate transcriptional
    responses to hypoxia. Acquisition of stemness characteristics in epithelial cells
    can be induced by activation of the EMT process. Ultimately, cancer cells show
    tumor initiation, metastasis, and resistance to therapy. Oct4, octamer-binding
    transcription factor 4; SOX2, sex determining region Y-box 2; Klf4, Kruppel-like
    factor 4; NF-κB, nuclear factor κB; PI3K, phosphoinositide 3-kinase; MAPK/ ERK,
    mitogen-activated protein kinase/extracellular signal-related kinase; JAK-STAT,
    Janus kinase-signal transducer and activator of transcription; VEGF, vascular
    endothelial growth factor; ALDH1, aldehyde dehydrogenase 1 family; ABC, ATP-binding
    cassette; CD, cluster of differentiation; ABCG2, ATP-binding cassette sub-family
    G member 2; ALDH1A1, aldehyde dehydrogenase 1 family, member A1; EpCAM, epithelial
    cell adhesion molecule; SSEA4, stage-specific embryonic antigen-4; CXCR4, C-X-C
    chemokine receptor type 4; BMI-1, B lymphoma Mo-MLV insertion region 1 homolog.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Itk
  - Slc22a3
  - Hif1a
  - Epas1
  - Tgfb1
  - Ltbp1
  - Nfkb1
  - Pik3r1
  - Ephb2
  - Mapk1
  - Eif2ak3
  - Lamp1
  - Twist1
  - Twist2
  - Snai1
  - Snai2
  - Zeb1
  - Zeb2
  - Pou5f1
  - Nanog
  - Sox2
  - Igkv4-53
  - Cdh1
  - Fzr1
  - Myc
  - Nol3
  - Cd44
  - Cdh2
  - Abcg2
  - Prom1
  - Cxcr4
  - Kit
  - Bmi1
  - Alcam
  - Vegfa
  - Aldh1a1
  - Epcam
  - Thy1
  - Wnt2
  - Pik3cg
  - Ephb1
  - Notch1
  - H2bc1
  - Qsox1
  - MDFIC
  - ITK
  - SLC22A3
  - HIF1A
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - TGFB1
  - TGFB2
  - TGFB3
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - NFKB1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - EPHB2
  - MAPK1
  - MAPK3
  - EIF2AK3
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - DHH
  - IHH
  - SHH
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - H1-0
  - H1-1
  - H1-2
  - H1-3
  - H1-4
  - H1-5
  - H1-6
  - H1-7
  - H1-8
  - H1-10
  - .na.character
  - H2AB1
  - H2AJ
  - H2AZ2
  - H2AX
  - MACROH2A1
  - MACROH2A2
  - H2AZ1
  - H2AC1
  - H2AC6
  - H2AC7
  - H2AC12
  - H2AC14
  - H2AC21
  - H2AC20
  - H2AC25
  - H2BC1
  - H2BC3
  - H2BC5
  - H2BC9
  - H2BC11
  - H2BC12
  - H2BC13
  - H2BC14
  - H2BC15
  - H2BC17
  - H2BC18
  - H2BC19P
  - H2BC20P
  - H2BC21
  - H2BC26
  - H2BC12L
  - H2BW2
  - H2BW1
  - H3-4
  - H3-5
  - H4C7
  - TWIST1
  - TWIST2
  - SNAI1
  - SNAI2
  - ZEB1
  - ZEB2
  - POU5F1
  - POU5F1P3
  - POU5F1P4
  - NANOG
  - SOX2
  - CDH1
  - FZR1
  - MYC
  - CD44
  - CDH2
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - ABCG2
  - PROM1
  - CXCR4
  - KIT
  - BMI1
  - COMMD3-BMI1
  - ALCAM
  - ABCB6
  - ALDH1A1
  - EPCAM
  - THY1
---
